$HROW.US ranked positive on December 23rd, 2022

Harrow Health Inc – (HROW, +1, Dec 23rd) Four insiders bought a total of $725,000 of stock on the 21-22nd December at approx $13.40. Most notably Mark Baum (CEO since 2012, founder) bought $325,000 increasing his stake by 2% in his first clean purchase on record despite a long tenure and Martin Makary (Non-Executive since […]

Read More